US Patent 7345054 Heterocyclic inhibitors of ERK2 and uses thereof

Patent 7345054 was granted and assigned to Vertex Pharmaceuticals on March, 2008 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

March 18, 2008

Patent Application Number

11077188

Date Filed

March 10, 2005

Patent Citations Received

Patent Primary Examiner

Patent abstract

Described herein are compounds that are useful as protein kinase inhibitors having the formula:

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7345054 Heterocyclic inhibitors of ERK2 and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.